- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05751200
Safety and Efficacy of Aortic Root Reinforcement Combined With Vascular Grafts Eversion and built-in Procedure (XJ-procedure) in Patients With Acute Type A Aortic Dissection (ADVANCED-XJ )
August 7, 2023 updated by: First Affiliated Hospital Xi'an Jiaotong University
Safety and Efficacy of Aortic Root Reinforcement Combined With Vascular Grafts Eversion and built-in Procedure (XJ-procedure) in Patients With Acute Type A Aortic Dissection (ADVANCED-XJ ): an Investigator-initiated, Single-center, Cohort Study
This is a retrospective study based on the data available in our hospital database for ATAAD patients from January 2020 to December 2021.
These patients were divided into two groups according to the surgical procedures of aortic root.
This study compared baseline data, perioperative and short-term follow-up results between the two groups to evaluate the efficacy and safety of XJ-procedure in ATAAD.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Acute type A aortic dissection (ATAAD) is a life-threatening disease with high mortality.
Surgery remains the gold standard for the treatment of ATAAD.
In recent years, ATAAD is still a persistent challenge for cardiovascular surgeons.
This is a retrospective study based on the data available in our hospital database for ATAAD patients undergoing total aortic arch replacement with elephant trunk stent under cryogenic stop circulation from January 2020 to December 2021.
These patients were divided into two groups according to the surgical procedures of aortic root: continuous aortic root suture group (CARS group); "aortic root reinforcement combined with vascular grafts eversion and built-in", which was created by our group and to be named as XJ-procedure (XJ-procedure group, XJ is an acronym for Xi'an Jiaotong University).
The main outcome was defined as 30-day mortality.
Secondary outcomes included the postoperative bleeding necessitating re-operation and the incidence of anastomotic pseudoaneurysm, residual aortic root dissection and severe aortic regurgitation before discharge and at 3 and 6 months after the operation.
This study compared baseline data, perioperative and short-term follow-up results between the two groups to evaluate the efficacy and safety of XJ-procedure in ATAAD.
Study Type
Observational
Enrollment (Actual)
183
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Shaanxi
-
Xi'an, Shaanxi, China, 710061
- The First Affiliated Hospital of Xi'an Jiaotong University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
The study enrolled patients who were diagnosed with ATAAD by computed tomography angiography (CTA) from January 2020 to December 2021 in the First Affiliated Hospital of Xi'an Jiaotong University.
Inclusion criteria included mild to moderate aortic root involvement, combined with aortic arch involvement undergoing Sun's procedure.
The exclusion criteria included severe aortic root involvement (root diameter >45 mm, root tear, severe disruption of aortic root, concomitant valve disease); the Bentall, Wheat or David procedure performed; recurrent ATAAD; preoperative severe brain complications (cerebral infarction, cerebral hemorrhage, coma, etc.), mal-perfusion of abdominal organs or lower extremities >12 h and incomplete clinical data.
Description
Inclusion Criteria:
- Diagnosed with ATAAD by computed tomography angiography (CTA) from January 2020 to December 2021 in the First Affiliated Hospital of Xi'an Jiaotong University
- Mild to moderate aortic root involvement
- Aortic arch involvement undergoing Sun's procedure
Exclusion Criteria:
- Patients with severe aortic root involvement (root diameter >45 mm, root tear, severe disruption of aortic root, concomitant valve disease)
- The Bentall, Wheat or David procedure performed
- Recurrent ATAAD
- Preoperative severe brain complications (cerebral infarction, cerebral hemorrhage, coma, etc.)
- Mal-perfusion of abdominal organs or lower extremities >12 h
- Incomplete clinical data.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
CARS group
In the CARS group, 3-0 polypropylene was used to suture the proximal end of aortic with the vascular grafts continuously, followed by one interrupted suture loop of 3-0 polypropylene for reinforcement.
|
No Intervention.
|
|
XJ-procedure group
In the XJ-procedure group, a 1.5-2cm wide bovine pericardial patch and graft ring were placed inside and outside the aortic root and against the aortic wall, respectively, and continuously sutured near the commissure using 5-0 polypropylene.
Then an eversion about 15mm of vascular graft was intermittently sutured to full layers of aortic vascular with 2-0 pad polyester sutures.
Finally, the eversion and aortic wall were continuously sutured together in one more turn.
|
No Intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
30-day mortality
Time Frame: Within 30 days after the surgery
|
Patients died within 30 days after the surgery.
Data were obtained from the medical records.
|
Within 30 days after the surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The postoperative bleeding necessitating re-operation
Time Frame: About 2 weeks after the surgery.
|
Postoperative bleeding necessitated reoperation during hospitalization.
Data were obtained from the surgical records and medical records.
|
About 2 weeks after the surgery.
|
|
Change in the incidence of anastomotic pseudoaneurysm
Time Frame: About 2 weeks after surgery, 3-month and 6-month follow-up.
|
The occurrence of anastomotic pseudoaneurysm was examined by postoperative computed tomography angiography examination.
|
About 2 weeks after surgery, 3-month and 6-month follow-up.
|
|
Change in the incidence of residual aortic root dissection
Time Frame: About 2 weeks after surgery, 3-month and 6-month follow-up.
|
The occurrence of residual aortic dissection was examined by postoperative computed tomography angiography examination.
|
About 2 weeks after surgery, 3-month and 6-month follow-up.
|
|
Change in the incidence of severe aortic regurgitation
Time Frame: About 2 weeks after surgery, 3-month and 6-month follow-up.
|
The occurrence of aortic valve regurgitation greater than grade2+, which was decided by cardiac ultrasonography.
|
About 2 weeks after surgery, 3-month and 6-month follow-up.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Yang Yan, First Affiliated Hospital Xi'an Jiaotong University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2023
Primary Completion (Actual)
March 2, 2023
Study Completion (Actual)
March 2, 2023
Study Registration Dates
First Submitted
February 14, 2023
First Submitted That Met QC Criteria
March 1, 2023
First Posted (Actual)
March 2, 2023
Study Record Updates
Last Update Posted (Actual)
August 9, 2023
Last Update Submitted That Met QC Criteria
August 7, 2023
Last Verified
August 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- XJTU1AF2023LSK-150
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.